04633nam 2201441z- 450 991058020310332120220706(CKB)5690000000012059(oapen)https://directory.doabooks.org/handle/20.500.12854/87430(oapen)doab87430(EXLCZ)99569000000001205920202207d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierTherapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug DevelopmentBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (334 p.)3-0365-3881-X 3-0365-3882-8 The importance of natural products, and especially plant secondary metabolites, for the treatment of diseases and drug development has already been obvious in medicine for several thousand years. Thus, this Special Issue of MDPI Biomedicines collects eight top articles from the field as regular full papers in addition to five reviews. All of the published papers are a vibrant source of information on the therapeutic potential of plant secondary metabolites in the treatment of diseases and drug development.Industrial chemistry and chemical engineeringbicsscTechnology: general issuesbicsscalkaloidsamide bondanabolicanti-HIV activityantimicrobial activityantiviral therapyartemisininbetulinic acidbevirimatbioavailabilityBODIPYcancercancer cellscannabichromenecannabidiol (CBD)cannabinoid receptors (CB1 and CB2)cannabinoidsCannabis sativa (Cannabis)capsaicinoidscardiometabolic diseasescell-cyclechloroquineCOVID-19curcumincurcumin analoguescurcumin delivery systemscurcumin derivativescytotoxicitydiabetesDuchenne muscular dystrophyecdysteroidecdysteroneEGFRendocannabinoidomefluorescent microscopyfood intakeHuisgen 1,3-dipolar cycloadditioninflammationivermectinlignanslipid accumulationlipidomicslipogenesislung cancerLXRαMAFLDmalariaMas1maturation inhibitormembrane fusionmetabolismmicrobiotaMMP2molecular ribbonmoxidectinmultifunctional PEG3 derivativen/anatural productnatural product synthesisnatural remedyNF-κB inhibitionNSCLCobesityonchocerciasisosteoporosisoverweightPapaver somniferum (opium poppy)PD-L1phytocannabinoidsphytochemicalquininerespiratory diseasessarcopeniaSARS-CoV-2secondary metabolitesSTAT3supramolecular self-assemblytanshinone IIAtetrahydrocannabinol (THC)thermos-TRPstriterpenoidTRPA1tumorsphereUnited States Food and Drug Administration-approved drugursolic acidvinblastinevincristineviral fusion inhibitorα,α-dimethylheptyl effectβ-ecdysoneIndustrial chemistry and chemical engineeringTechnology: general issuesDrašar Pavel Bedt1303416Drašar Pavel BothBOOK9910580203103321Therapeutic Potential of Plant Secondary Metabolites in the Treatment of Diseases and Drug Development3027019UNINA